VistaPath, PathAI validate automated tissue platform

2021 12 28 22 24 9067 Lab Scientist Computer Ai 400

Pathology firm VistaPath on Thursday announced that its VistaPath Sentinel automated tissue grossing platform has been validated in a clinical setting in a collaboration with PathAI.

"Despite informing a majority of clinical decisions, anatomical pathology still prepares samples for diagnosis manually, in stark contrast to other clinical lab services," Timothy Spong, CEO of VistaPath, noted in a statement.

Sentinel aims to make tissue grossing faster, safer, and easier, using a high-quality video system to assess specimens. It creates a gross report 93% faster than human technicians with 43% greater accuracy, the firm said.

Page 1 of 164
Next Page